TRT and Libido/Erections: Does Testosterone Really Improve Your Sex Life?

'I started TRT because I had erection problems, and my testosterone came back low' — this is one of the most common sentences heard in clinics dealing with testosterone replacement therapy. The problem is that libido (the need and desire for sex) and erectile function (the ability to achieve and maintain one) are two different physiological processes, governed largely by different mechanisms. Testosterone has a strong, well-documented effect on the first. On the second, its effect is real but far more limited, conditional, and dependent on everything else going on in a man's body.

This distinction isn't an academic subtlety — it has direct clinical significance. A man who starts TRT purely hoping for better erections, while skipping a proper workup of what's actually causing his erectile dysfunction (ED), might, after a few months of therapy, have clearly higher libido and the exact same erection problem — because the cause lay elsewhere. This article lays out, honestly, what TRT actually delivers in the sexual domain and what it doesn't, based on the available clinical research.

Of all the symptoms of hypogonadism, libido responds to normalized testosterone the most predictably and to the greatest degree. The mechanism is well understood — androgen receptors in the hypothalamus and limbic system directly modulate sexual drive, and testosterone acts here almost like a switch: at levels clearly below normal, drive drops, and restoring the hormone to a physiological range usually restores the desire for sex as well.

An erection is a vascular-neural process: sexual arousal releases nitric oxide (NO) in penile tissue, which activates the enzyme guanylate cyclase, raising cGMP, relaxing smooth muscle in the corpora cavernosa, and drawing in blood flow. Testosterone plays a permissive role in this chain, not a driving one — it maintains the density and sensitivity of receptors in penile tissue, supports nitric oxide synthase activity, and indirectly affects phosphodiesterase type 5 (PDE5, the same enzyme blocked by drugs like sildenafil or tadalafil). In other words: testosterone 'lubricates' the mechanism, but it doesn't power it.

This explains why erections are far less sensitive to testosterone normalization alone than libido is. Even at a normal hormone level, if the blood vessels in the penis are damaged (atherosclerosis, diabetes, hypertension), the nerves responsible for carrying the signal are damaged (e.g. after prostate surgery, in diabetic neuropathy), or a psychological factor dominates (fear of failure, depression, stress, relationship problems) — raising testosterone alone won't fix those pieces of the puzzle.

The prevalence of erectile dysfunction rises with age alongside the prevalence of cardiovascular disease, type 2 diabetes, hypertension, and lipid disorders — and that's not a coincidence. The vascular endothelium of the penis is unusually sensitive to metabolic damage, often earlier than the larger coronary vessels, which is why erectile dysfunction is sometimes called an early 'marker' of cardiovascular disease, appearing before its classic symptoms show up. In a man over 40-50 with ED, the natural question shouldn't just be 'does he have low testosterone,' but above all: what's the state of his vessels, blood glucose, blood pressure, lipid profile, and what medications does he take regularly?

The most practical data address a clinical situation that comes up very often in practice: a man with confirmed hypogonadism and ED who isn't responding adequately to a PDE5 inhibitor alone. It's precisely in this group that studies show a clear advantage of combination therapy over continuing the oral medication by itself.

One of the most common sources of disappointment with TRT is mismatched expectations about how fast effects appear. Libido and erections improve on completely different timelines — and it's worth knowing that before writing off the therapy as ineffective after six weeks.

An honest approach to ED starts not with a prescription, but with the question 'why this particular man.' Besides measuring testosterone (ideally morning, repeated, with free testosterone and SHBG — see our article on diagnosing hypogonadism), it's worth assessing vascular, metabolic, neurological, iatrogenic (medication-related), and psychological factors. A nocturnal erection test (checking for normal erections during sleep despite an absence of erections in sexual situations) can be a useful, cheap tool for distinguishing an organic cause from a psychogenic one.

TRT is a legal, well-studied, and in many situations well-justified therapy — but it isn't a universal cure for erectile dysfunction. If the main problem is a drop in libido in a man with confirmed hypogonadism, you can expect a clear, reasonably fast improvement. If the main problem is erections, especially in a man over 40-50, it's worth treating TRT from the start as one possible piece of the treatment, not the whole of it — and being prepared that a full solution may require adding a PDE5 inhibitor, addressing vascular-metabolic factors, or psychological or sexological support.